Supernus Pharmaceuticals
SUPN
#4185
Rank
โ‚ฌ2.05 B
Marketcap
37,23ย โ‚ฌ
Share price
1.30%
Change (1 day)
43.15%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2024 (TTM): โ‚ฌ65.89 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.65 Billion. In 2023 the company made an earning of โ‚ฌ5.03 Million a decrease over its 2022 earnings that were of โ‚ฌ65.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ65.89 M1207.82%
2023 โ‚ฌ5.03 M-92.36%
2022 โ‚ฌ65.9 M-29.8%
2021 โ‚ฌ93.88 M-49.79%
2020 โ‚ฌ0.18 B12.99%
2019 โ‚ฌ0.16 B7.58%
2018 โ‚ฌ0.15 B54.9%
2017 โ‚ฌ99.31 M84.25%
2016 โ‚ฌ53.9 M202.27%
2015 โ‚ฌ17.83 M-462.04%
2014 -โ‚ฌ4.93 Million-94%
2013 -โ‚ฌ82.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.21 Billion-392.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.44 B 1,953.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.86 B 13,904.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ6.69 Billion-9,592.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.58 B 9,251.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.87 B 25,280.12%๐Ÿ‡บ๐Ÿ‡ธ USA